On April 29, over 175 NASH stakeholders from across the globe will meet virtually to hear 20 presentations from leaders in academia and industry. SurfingNASH has selected 9 presentations to discuss in a session we will record right after the conference concludes. The speakers and their broad topic areas are:
Naim Alkhouri — novel anti-fibrotic drugs for advanced NASH and cirrhosis
Ian Rowe — Population Health Strategies for America’s Veterans with NAFLD
Suneil Hosmane — Diet and exercise therapies for Fatty Liver patients
Louise Campbell — Genomic and transcriptomic analysis of NAFLD; differences in knowledge between different physician groups
Roger Green — Novel anti-fibrotic drugs for advanced NASH

TOPICS: aldafermin, cirrhosis, FGF-21, Fibrosis Level 3, Fibrosis Level 4, Genfit, Madrigal, NAFLD, NASH, NGM Biopharmaceuticals, non-invasive liver testing, Hepion Pharmaceuticals, CRV431, FGF-19, Aramchol, Galmed, Galectin, Belapectin, Theratechnologies, tesamorelin, Accelerated Enrollment Solutions,

Surfing The NASH Tsunami is brought to you by HEP Dynamics
#HEPdynamics #SurfingNASH #podcast